Both in Pharmaceuticals
Vera Therapeutics vs Aurinia Pharmaceuticals
Over the past year VERA returned +18.4% and AUPH returned +25.7%; their daily moves had a correlation of 0.20.
VERA +18.4% AUPH +25.7%Growth of $1, one year, split-adjusted
| Metric | VERA | AUPH |
|---|---|---|
| Price | $30.71 | $16.56 |
| Market cap | $2.21B | $2.22B |
| Today | +1.52% | +2.60% |
| 1 month | +3.0% | +5.3% |
| 6 months | −11.0% | +3.2% |
| Year to date | −39.4% | +3.8% |
| 1 year | +7.9% | +25.7% |
| Revenue growth (YoY) | — | +13.9% |
| Gross margin | — | 90.1% |
| Net margin | — | 37.9% |
| P/E (TTM) | — | 7.1× |
| Price / sales | — | 6.9× |
| Net cash | $423.9M | $431.7M |
| Dividend yield | — | — |
| Volatility (60d) | 59.7% | 30.3% |
| Short % of float | 21.5% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).